Aug 14, 2019
Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical's Phase 2 Clinical Trial
May 31, 2019
AIVITA Biomedical to Present at Oncology, Biotech and Aesthetics Conferences in June
May 08, 2019
AIVITA Biomedical to Present at Aesthetics and Regenerative Medicine Conferences in May
Feb 05, 2019
Predictive Markers of Survival Identified for Next Generation Cancer Stem Cell Vaccine
Jan 16, 2019
AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial
Jan 03, 2019
AIVITA Biomedical to Present at Biotech Showcase 2019
Nov 16, 2018
AIVITA Biomedical Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial
Oct 30, 2018
AIVITA Biomedical Consumer Skincare Line ROOT OF SKIN(TM) to Be Sold on Home Shopping Channel QVC Japan
Oct 23, 2018
AIVITA Biomedical Appoints Paul Jenkinson and Philippe Schaison to its Board of Directors
Oct 12, 2018
AIVITA Biomedical Attains Japanese PMDA Milestone for ROOT OF CANCER Technology
Sep 20, 2018
AIVITA Biomedical Announces Treatment of First Patient in Phase 2 Ovarian Cancer Trial
Aug 16, 2018
AIVITA Biomedical Appoints Chief Financial Officer and Vice President of Business Development
Aug 14, 2018
AIVITA Biomedical Announces Initiation of First Clinical Site for ROOT OF CANCER Glioblastoma Trial
Jun 20, 2018
AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
Jun 14, 2018
AIVITA Biomedical Randomizes First Patient in Phase II Ovarian Cancer Trial
Jun 11, 2018
AIVITA Biomedical Raises $15M USD in Series B Financing
Apr 11, 2018
AIVITA Biomedical CEO Hans Keirstead to Deliver Plenary Keynote at GTCbio's 15th Stem Cell Summit
Feb 27, 2018
AIVITA Biomedical to Participate at Upcoming February and March Aesthetic & Dermatology Conferences
Sep 19, 2017
AIVITA Biomedical Announces New Discovery with Applications to Regenerative Medicine, Skin Aging and Hair Growth
Jun 13, 2017
AIVITA Comments on Positive Findings from Asterias' SCiStar Trial for Spinal Cord Injury